Is Finecure Pharmaceuticals a good quality company?

Data is not available for this company.

What is Finecure Pharmaceuticals share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Finecure Pharmaceuticals?

The latest standalone P/E ratio of Finecure Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Finecure Pharmaceuticals?

The latest standalone P/B ratio of Finecure Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Finecure Pharmaceuticals?

The 52-week high of Finecure Pharmaceuticals is Rs. 0.00 and the 52-week low is Rs. 0.00.

Finecure Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Finecure Pharmaceuticals
Brand: Finecure Pharmaceuticals

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Finecure Pharma

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Finecure Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	30%	32.2%	34.1%	27.7%	37.2%	43%	38.1%	32.7%	25.7%	-
Value Creation Index ⓘ	1.1	1.3	1.4	1.0	1.7	2.1	1.7	1.3	0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	15	20	31.2	44.8	65.1	87.2	98.6	115	124	124
Sales YoY Gr.	-	33.3%	55.7%	43.8%	45.3%	34%	13.1%	17.1%	7.4%	-
Adj EPS ⓘ	1.9	2.5	3.3	3.5	5.7	8.8	10.7	10.6	10.3	10.5
YoY Gr.	-	30.4%	33.3%	4.8%	62.9%	55.9%	20.7%	-0.6%	-2.7%	-
BVPS (₹) ⓘ	7.8	10.3	13.5	16.8	22.4	30.8	41.4	51.9	62.6	62.6
Adj Net Profit ⓘ	2.4	3.2	4.2	4.4	7.2	11.2	13.6	13.5	13.1	13
Cash Flow from Ops. ⓘ	0	0	0	2.9	7.6	11.7	11	12.9	11.4	-
Debt/CF from Ops. ⓘ	0	0	0	0.2	0	0.1	0.1	0.1	0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	22.6%	12.4%	7.4%
Adj EPS ⓘ	NA	24.3%	5.3%	-2.7%
BVPSⓘ	NA	30.1%	26.7%	20.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	24.5	27.5	27.9	22.9	29	33.3	29.5	22.7	18	16.8
Op. Profit Mgn % ⓘ	22.5	20.8	17.7	12.5	14.4	16.8	18.7	17.5	16.2	NAN
Net Profit Mgn % ⓘ	16.2	15.8	13.5	9.9	11.1	12.9	13.8	11.7	10.6	10.8
Debt to Equity ⓘ	0.1	0.1	0.1	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	150	123	117	104	96	97	107	122	0
Cash Conv. Cycle ⓘ	0	69	52	52	44	36	37	28	24	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Finecure Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	10.5	0
TTM Sales (₹ Cr.)	124	0
BVPS (₹.) ⓘ	62.6	10
Reserves (₹ Cr.) ⓘ	67	-
P/BV ⓘ	0.00	0.00
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	12.7
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Finecure Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Finecure Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Finecure Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	15.03	20.03	31.18	44.84	65.13	87.24	98.64	115.46	123.98
Operating Expenses ⓘ	11.64	15.86	25.66	39.25	55.84	72.61	80.22	95.25	103.96
Manufacturing Costs	0.37	0.58	0.97	1.12	1.42	2.17	1.39	1.74	1.76
Material Costs	7.94	11.07	18.12	30.24	42.79	57.35	61	72.87	79.18
Employee Cost	1.09	1.67	2.59	3.40	4.71	6.22	7.15	9.04	9.66
Other Costs ⓘ	2.24	2.54	3.98	4.49	6.93	6.87	10.69	11.60	13.36
Operating Profit ⓘ	3.38	4.17	5.51	5.59	9.29	14.63	18.41	20.21	20.02
Operating Profit Margin (%)	22.5%	20.8%	17.7%	12.5%	14.3%	16.8%	18.7%	17.5%	16.1%
Other Income ⓘ	0.38	0.54	0.73	0.92	0.69	1.04	0.52	1.37	0.61
Interest ⓘ	0.07	0.04	0.07	0.06	0.10	0.10	0.19	0.21	0.16
Depreciation ⓘ	0.58	0.71	0.65	0.89	0.55	0.95	1.06	1.32	1.57
Exceptional Items ⓘ	0	0	0	0	0	0	0	-0.39	0
Profit Before Tax ⓘ	3.11	3.96	5.52	5.56	9.33	14.61	17.68	19.67	18.90
Tax ⓘ	0.62	0.79	1.31	1.14	2.09	3.36	4.03	5.86	5.56
Profit After Tax	2.49	3.17	4.21	4.41	7.24	11.26	13.65	13.81	13.34
PAT Margin (%)	16.6%	15.8%	13.5%	9.8%	11.1%	12.9%	13.8%	12.0%	10.8%
Adjusted EPS (₹)	2.0	2.5	3.3	3.5	5.7	8.9	10.7	10.9	10.5
Dividend Payout Ratio (%)	0%	0%	3%	4%	2%	1%	1%	12%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund	9.93	13.09	17.15	21.38	28.40	39.18	52.64	66.25	79.59
Share Capital ⓘ	1.27	1.27	1.27	1.27	1.27	1.27	1.27	12.71	12.71
Reserves ⓘ	8.66	11.82	15.88	20.11	27.13	37.91	51.37	53.55	66.88
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	0.67	1.10	1.44	0.67	0.26	0.55	0.93	0.78	1.06
Long Term Debt	0	0	0.06	0.01	0.25	0.29	0.93	0.40	0.24
Short Term Debt	0.67	1.10	1.38	0.66	0.01	0.26	0	0.38	0.81
Trade Payables	1.70	3.89	5.13	7.50	8.73	12.81	9.59	21.71	21.29
Others Liabilities ⓘ	1.22	1.27	1.89	2.40	4.43	5.38	6.56	6.23	4.66
Total Liabilities ⓘ	13.53	19.36	25.61	31.95	41.82	57.92	69.72	94.98	106.60
Fixed Assets
Gross Block	7.90	9.24	11.56	13.08	14.61	16.62	23.39	26.67	45.61
Accumulated Depreciation	1.90	2.62	3.46	4.35	4.91	5.87	6.93	8.24	9.72
Net Fixed Assetsⓘ	6	6.62	8.10	8.73	9.70	10.76	16.46	18.42	35.89
CWIP ⓘ	0	0	0	0.41	6.73	9.22	15.65	25.63	16.67
Investmentsⓘ	0.16	0.16	1.55	1.83	3.01	4.56	4.12	5.44	5.69
Inventories	3.63	4.86	6.29	9.12	10.23	11.46	12.14	16.26	20.25
Trade Receivables	2.46	3.66	4.86	6.79	8.45	13.02	12.71	17.06	15.77
Cash Equivalents	0.18	3.36	4.10	4.09	2.10	7.96	6.51	4.55	5.83
Others Assetsⓘ	1.10	0.70	0.71	0.98	1.59	0.94	2.14	7.62	6.49
Total Assets ⓘ	13.53	19.36	25.61	31.95	41.82	57.92	69.72	94.98	106.60

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ	2.87	7.59	11.70	11.01	12.86	11.37
PBT ⓘ	5.56	9.33	14.61	17.68	19.67	18.90
Adjustment ⓘ	0.63	0.56	0.58	0.96	1.21	1.60
Changes in Working Capital ⓘ	-1.98	-0.9	-0.58	-3.5	-2.41	-3.05
Tax Paid ⓘ	-1.34	-1.40	-2.91	-4.13	-5.61	-6.08
Cash Flow From Investing Activity ⓘ	-1.89	-8.81	-5.81	-12.45	-14.27	-10.21
Capex	-1.70	-7.89	-4.42	-13.19	-13.26	-10.08
Net Investments	-0.28	-1.19	-1.55	0	0	0
Others ⓘ	0.08	0.27	0.16	0.74	-1.01	-0.13
Cash Flow From Financing Activityⓘ	-0.98	-0.77	-0.04	0	-0.55	0.12
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.05	0.20	0.28	0	0	0
Interest Paid ⓘ	-0.06	-0.14	-0.14	-0.19	0	0
Dividend Paid ⓘ	-0.15	-0.16	-0.19	-0.16	-0.19	0
Others ⓘ	-0.72	-0.67	0	0.35	-0.36	0.12
Net Cash Flow ⓘ	0	-1.99	5.85	-1.44	-1.97	1.28

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	25.05	27.5	27.81	22.91	29.08	33.32	29.73	23.29	18.33
ROCE (%)	30.01	32.23	34.12	27.66	37.19	43.02	38.05	32.73	25.74
Asset Turnover Ratio	1.11	1.22	1.39	1.56	1.77	1.75	1.55	1.4	1.23
PAT to CFO Conversion(x)	1.15	2.39	2.78	2.5	1.78	1.01	0	0	0
Working Capital Days
Receivable Days	60	56	50	47	43	45	48	47	48
Inventory Days	88	77	65	63	54	45	44	45	54
Payable Days	78	92	91	76	69	69	67	78	99

Finecure Pharmaceuticals Ltd Stock News

Finecure Pharmaceuticals Ltd FAQs

What is the share price of Finecure Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Finecure Pharma on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Finecure Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Finecure Pharma stood at ₹0.00.